These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
827 related items for PubMed ID: 28490807
21. Inhibition of Prostate Cancer DU-145 Cells Proliferation by Anthopleura anjunae Oligopeptide (YVPGP) via PI3K/AKT/mTOR Signaling Pathway. Li X, Tang Y, Yu F, Sun Y, Huang F, Chen Y, Yang Z, Ding G. Mar Drugs; 2018 Sep 11; 16(9):. PubMed ID: 30208576 [Abstract] [Full Text] [Related]
22. Synergistic targeted inhibition of MEK and dual PI3K/mTOR diminishes viability and inhibits tumor growth of canine melanoma underscoring its utility as a preclinical model for human mucosal melanoma. Wei BR, Michael HT, Halsey CH, Peer CJ, Adhikari A, Dwyer JE, Hoover SB, El Meskini R, Kozlov S, Weaver Ohler Z, Figg WD, Merlino G, Simpson RM. Pigment Cell Melanoma Res; 2016 Nov 11; 29(6):643-655. PubMed ID: 27463366 [Abstract] [Full Text] [Related]
23. A Ferulic Acid Derivative FXS-3 Inhibits Proliferation and Metastasis of Human Lung Cancer A549 Cells via Positive JNK Signaling Pathway and Negative ERK/p38, AKT/mTOR and MEK/ERK Signaling Pathways. Yue SJ, Zhang PX, Zhu Y, Li NG, Chen YY, Li JJ, Zhang S, Jin RY, Yan H, Shi XQ, Tang YP, Duan JA. Molecules; 2019 Jun 08; 24(11):. PubMed ID: 31181779 [Abstract] [Full Text] [Related]
24. Shikonin inhibits prostate cancer cells metastasis by reducing matrix metalloproteinase-2/-9 expression via AKT/mTOR and ROS/ERK1/2 pathways. Chen Y, Zheng L, Liu J, Zhou Z, Cao X, Lv X, Chen F. Int Immunopharmacol; 2014 Aug 08; 21(2):447-55. PubMed ID: 24905636 [Abstract] [Full Text] [Related]
25. Calycosin, a Phytoestrogen Isoflavone, Induces Apoptosis of Estrogen Receptor-Positive MG-63 Osteosarcoma Cells via the Phosphatidylinositol 3-Kinase (PI3K)/AKT/Mammalian Target of Rapamycin (mTOR) Pathway. Sun H, Yin M, Qian W, Yin H. Med Sci Monit; 2018 Sep 05; 24():6178-6186. PubMed ID: 30182951 [Abstract] [Full Text] [Related]
26. Polyphyllin I Promoted Melanoma Cells Autophagy and Apoptosis via PI3K/Akt/mTOR Signaling Pathway. Long J, Pi X. Biomed Res Int; 2020 Sep 05; 2020():5149417. PubMed ID: 32733943 [Abstract] [Full Text] [Related]
27. Tormentic acid induces anticancer effects in cisplatin-resistant human cervical cancer cells mediated via cell cycle arrest, ROS production, and targeting mTOR/PI3K/AKT signalling pathway. Wu J, Wang N, Jin G, Xue L. J BUON; 2020 Sep 05; 25(1):74-79. PubMed ID: 32277616 [Abstract] [Full Text] [Related]
28. Danusertib Induces Apoptosis, Cell Cycle Arrest, and Autophagy but Inhibits Epithelial to Mesenchymal Transition Involving PI3K/Akt/mTOR Signaling Pathway in Human Ovarian Cancer Cells. Zi D, Zhou ZW, Yang YJ, Huang L, Zhou ZL, He SM, He ZX, Zhou SF. Int J Mol Sci; 2015 Nov 13; 16(11):27228-51. PubMed ID: 26580601 [Abstract] [Full Text] [Related]
29. Inhibition of PI3K/Akt/mTOR pathway by apigenin induces apoptosis and autophagy in hepatocellular carcinoma cells. Yang J, Pi C, Wang G. Biomed Pharmacother; 2018 Jul 13; 103():699-707. PubMed ID: 29680738 [Abstract] [Full Text] [Related]
30. Coptisine-induced apoptosis in human colon cancer cells (HCT-116) is mediated by PI3K/Akt and mitochondrial-associated apoptotic pathway. Han B, Jiang P, Li Z, Yu Y, Huang T, Ye X, Li X. Phytomedicine; 2018 Sep 15; 48():152-160. PubMed ID: 30195873 [Abstract] [Full Text] [Related]
31. Oxymatrine synergistically enhances antitumor activity of oxaliplatin in colon carcinoma through PI3K/AKT/mTOR pathway. Liu Y, Bi T, Wang Z, Wu G, Qian L, Gao Q, Shen G. Apoptosis; 2016 Dec 15; 21(12):1398-1407. PubMed ID: 27671687 [Abstract] [Full Text] [Related]
32. Indomethacin induces apoptosis in 786-O renal cell carcinoma cells by activating mitogen-activated protein kinases and AKT. Ou YC, Yang CR, Cheng CL, Raung SL, Hung YY, Chen CJ. Eur J Pharmacol; 2007 Jun 01; 563(1-3):49-60. PubMed ID: 17341418 [Abstract] [Full Text] [Related]
33. Chamaejasmine induces apoptosis in HeLa cells through the PI3K/Akt signaling pathway. Qian S, Li M. Anticancer Drugs; 2017 Jan 01; 28(1):40-50. PubMed ID: 27557139 [Abstract] [Full Text] [Related]
34. Licochalcone A-induced human gastric cancer BGC-823 cells apoptosis by regulating ROS-mediated MAPKs and PI3K/AKT signaling pathways. Hao W, Yuan X, Yu L, Gao C, Sun X, Wang D, Zheng Q. Sci Rep; 2015 May 18; 5():10336. PubMed ID: 25981581 [Abstract] [Full Text] [Related]
35. Knockdown of hnRNP A2/B1 inhibits cell proliferation, invasion and cell cycle triggering apoptosis in cervical cancer via PI3K/AKT signaling pathway. Shi X, Ran L, Liu Y, Zhong SH, Zhou PP, Liao MX, Fang W. Oncol Rep; 2018 Mar 18; 39(3):939-950. PubMed ID: 29328485 [Abstract] [Full Text] [Related]
36. Huachansu Capsule inhibits the proliferation of human gastric cancer cells via Akt/mTOR pathway. Ni T, Wang H, Li D, Tao L, Lv M, Jin F, Wang W, Feng J, Qian Y, Sunagawa M, Liu Y. Biomed Pharmacother; 2019 Oct 18; 118():109241. PubMed ID: 31351435 [Abstract] [Full Text] [Related]
37. Berberine could inhibit thyroid carcinoma cells by inducing mitochondrial apoptosis, G0/G1 cell cycle arrest and suppressing migration via PI3K-AKT and MAPK signaling pathways. Li L, Wang X, Sharvan R, Gao J, Qu S. Biomed Pharmacother; 2017 Nov 18; 95():1225-1231. PubMed ID: 28931215 [Abstract] [Full Text] [Related]
38. Liquiritigenin Induces Cell Cycle Arrest and Apoptosis in Lung Squamous Cell Carcinoma. Liu Y, Wang Y, Yang Y, Quan Y, Guo M. Cell Biochem Biophys; 2024 Jun 18; 82(2):1397-1407. PubMed ID: 38775930 [Abstract] [Full Text] [Related]
39. Anticancer activity of Eremanthin against the human cervical cancer cells is due to G2/M phase cell cycle arrest, ROS-mediated necrosis-like cell death and inhibition of PI3K/AKT signalling pathway. Liu T, Zhao X, Song D, Liu Y, Kong W. J BUON; 2020 Jun 18; 25(3):1547-1553. PubMed ID: 32862603 [Abstract] [Full Text] [Related]
40. β-Elemene induces apoptosis in human renal-cell carcinoma 786-0 cells through inhibition of MAPK/ERK and PI3K/Akt/ mTOR signalling pathways. Zhan YH, Liu J, Qu XJ, Hou KZ, Wang KF, Liu YP, Wu B. Asian Pac J Cancer Prev; 2012 Jun 18; 13(6):2739-44. PubMed ID: 22938451 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]